IDH2 and astrocytoma (excluding glioblastoma): Due to the presence of CDKN2A HD, the CNS WHO grade of 10 (11.3%) IDH-mutant astrocytomas was upgraded to grade 4 (2 were previously grade II, 8 were previously grade III according to the WHO 2016 at the time of diagnosis).